Joining forces for your staff:
Corporate Oncology Program for Employees

Expand your health program with molecular tumor diagnostics

A cancer diagnosis changes everything. It affects your private life and your professional life, a huge challenge for any person. It can also impact every company, as employees are the most valuable assets a company has.

With our Corporate Oncology Program for Employees (COPE), companies have the opportunity to give impacted employees straightforward access to comprehensive tumor diagnostics and evaluation as part of a health management program. This can help cancer patients receive better treatment.

Together against cancer – with COPE

Molecular Health, a company of dievini Hopp Biotech holding GmbH & Co. KG, has developed a groundbreaking software solution that gives physicians personalized treatment options for individual patients. This solution – MH Guide – is the first software of its kind registered as an in-vitro diagnostic (IVD) medical device in Europe. MH Guide analyzes and interprets the patient’s genetic tumor profile. Based on these results, the attending physician can, if necessary, identify suitable drugs or clinical trials for individualized treatment.

Dr. Friedrich von Bohlen 
Chief Executive Officer

“With our COPE program, we offer other companies access to our patient-centered solutions, so that they can support their workforce in the best possible way.” 

How your company can benefit from COPE

Simple implementation

If you and Molecular Health have implemented COPE in your company, employees wanting participate in the program only need to contact your company physician or your company’s trust center.

Please have a little patience. We are currently updating this brochure.

COPE-Partner

“Our employees are the heart of our company. If anyone gets cancer, we want to ensure that they receive the best possible diagnostics and the most suitable therapy. COPE lets us do this.” 

Dr. Natalie Lotzmann
Leitung Globales Gesundheitsmanagement 
SAP SE, Walldorf

Protection of personal data is of utmost importance

All patients can be sure that none of their personal data will be passed on to Molecular Health by their employer or physician.

Only the attending physician and the molecular pathologist have access to patient data that allow conclusions to be drawn about identity. Molecular Health works exclusively with pseudonymized data.

Contact form